Search - tctmd.com

Displaying 421 - 440 of 1576

Sort: Relevancy | Date

Presentation TCT 2017

The High-Bleeding-Risk Patient: Physician-Scientist Perspectives on Appropriate Patients and DAPT Duration

Presenter: Mitchell W. Krucoff, P.F. Adrian Magee, Marie-Claude Morice

October 31, 2017

Presentation TCT 2017

TCT 93: Stent-Based Tissue Drug and Binding Target Protein Distributions - Durable vs Deployable Coatings

Presenter: Francesco Prati, Renu Virmani, Abraham Tzafriri, MD

October 31, 2017

Presentation TCT 2017

TCT 83: Provisional vs Planned Two-Stent Technique in Patients With Distal Bifurcation Left Main Disease Undergoing PCI: The EXCEL Trial

Presenter: David Hildick-Smith, Nicholas J. Lembo, David E. Kandzari

October 31, 2017

Presentation TCT 2017

TCT 5: Complete vs Culprit Only Lesion Intervention in ACS Patients With Multivessel Disease - Incidence and Outcomes From The London Heart Attack Group

Presenter: David A. Cox, Alice K. Jacobs, Krishnaraj Rathod, MD

October 31, 2017

Presentation TCT 2017

TCT 21: Prevalence, Presentation and Treatment of Balloon Undilatable Chronic Total Occlusions: Multicenter US Experience

Presenter: Alfredo R. Galassi, Jonathan M. Hill, Peter Tajti, MD

October 31, 2017

Presentation TCT 2017

TCT 179: Outcomes after Left Main PCI vs CABG According to Ostial/Shaft vs Distal Bifurcation Involvement: Insights From the EXCEL Trial

Presenter: Davide Capodanno, Tullio Palmerini, Anthony H. Gershlick

October 31, 2017

Presentation TCT 2017

TCT 14: Safety and Clinical Performance of the Drug-Eluting Absorbable Metal Scaffold in the Treatment of Subjects With De Novo Lesions in Native Coronary Arteries at 12-Month Follow-up - BIOSOLVE-II and BIOSOLVE-III

Presenter: Stephan Achenbach, Jacques J. Koolen, Ron Waksman

October 31, 2017

Presentation TCT 2017

FAVOR II Europe Japan: Diagnostic Accuracy of the Angiographic Quantitative Flow Ratio in Patients With Coronary Artery Disease

Presenter: Robert-Jan van Geuns, Jelmer Westra

October 31, 2017

REVASCTO PCI Does Not Improve LV Function but Seems to Provide Symptom Relief

News Conference News TCT 2017

REVASC: CTO PCI Does Not Improve LV Function but Seems to Provide Symptom Relief

Todd Neale

October 31, 2017

Presentation TCT 2017

TCT 76: Impact of Post-Discharge Dual Antiplatelet Therapy vs Aspirin Alone After CABG in Patients With Left Main Disease: Results from the EXCEL Trial

Presenter: Adrian P. Banning, John D. Puskas, Christopher Kelly, MD

October 31, 2017

Presentation TCT 2017

TCT 4: Prognostic Impact of Nonculprit Chronic Total Occlusions in Infarct-Related Cardiogenic Shock - Results of the Randomized IABP-SHOCK II Trial

Presenter: Rajesh M. Dave, A. Michael Lincoff, Mohammed Saad, MD

October 31, 2017

Presentation TCT 2017

TCT 20: Ten-year Clinical Outcome in Patients With Coronary Chronic Total Occlusions not Revascularized by Percutaneous Coronary Intervention According to Left Ventricle Systolic Function

Presenter: James C. Spratt, R. Michael Wyman, Cosmo Godino, MD

October 31, 2017

Presentation TCT 2017

TCT 12: Clinical, Angiographic, and Procedural Correlates of Very Late Absorb Scaffold Thrombosis Multistudy Registry Results

Presenter: Yoshinobu Onuma, Joanna J. Wykrzykowska, Stephen G. Ellis

October 31, 2017

Presentation TCT 2017

RECAP: A Sham-Controlled Randomized Trial of Radiation Protection in Patients Undergoing PCI

Presenter: David P. Faxon, Joseph A. Hill, Wieneke Vlastra

October 31, 2017

News Conference News TCT 2017

Long-term Absorb BVS Data Continue to Disappoint

Michael O'Riordan

October 31, 2017

Presentation TCT 2017

FAVOR II China: Diagnostic Accuracy of the Angiographic Quantitative Flow Ratio in Patients With Coronary Artery Disease

Presenter: Robert-Jan van Geuns, Bo Xu

October 31, 2017

Presentation TCT 2017

ABSORB PSP: Impact of Technique on Early and Late Outcomes Following Coronary Bioresorbable Scaffold Implantation

Presenter: Y. S. Chandrashekhar, David J. Moliterno, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

VALIDATE-SWEDEHEART STEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With STEMI

Presenter: Y. S. Chandrashekhar, David J. Moliterno, Stefan K. James

October 31, 2017

Presentation TCT 2017

TCT 9: Absorb Bioresorbable Vascular Scaffold vs Everolimus-Eluting Metallic Stent in Small Vessel Disease -A Propensity Matched Analysis of COMPARE II, RAI, and MAASSTAD-ABSORB Prospective Studies

Presenter: Yoshinobu Onuma, Joanna J. Wykrzykowska, Alberto Barioli, MD

October 31, 2017

Presentation TCT 2017

TCT 99: Safety and Efficacy of Percutaneous Axillary Artery Access for Mechanical Circulatory Support With the Impella© Devices: An Initial Evaluation From the Axillary Access Registry to Monitor Safety (ARMS) MultiCenter Registry

Presenter: Vladimir Dzavik, Srihari S. Naidu, James M. McCabe

October 31, 2017

Advertisement

The High-Bleeding-Risk Patient: Physician-Scientist Perspectives on Appropriate Patients and DAPT Duration

TCT 93: Stent-Based Tissue Drug and Binding Target Protein Distributions - Durable vs Deployable Coatings

TCT 83: Provisional vs Planned Two-Stent Technique in Patients With Distal Bifurcation Left Main Disease Undergoing PCI: The EXCEL Trial

TCT 5: Complete vs Culprit Only Lesion Intervention in ACS Patients With Multivessel Disease - Incidence and Outcomes From The London Heart Attack Group

TCT 21: Prevalence, Presentation and Treatment of Balloon Undilatable Chronic Total Occlusions: Multicenter US Experience

TCT 179: Outcomes after Left Main PCI vs CABG According to Ostial/Shaft vs Distal Bifurcation Involvement: Insights From the EXCEL Trial

TCT 14: Safety and Clinical Performance of the Drug-Eluting Absorbable Metal Scaffold in the Treatment of Subjects With De Novo Lesions in Native Coronary Arteries at 12-Month Follow-up - BIOSOLVE-II and BIOSOLVE-III

FAVOR II Europe Japan: Diagnostic Accuracy of the Angiographic Quantitative Flow Ratio in Patients With Coronary Artery Disease

REVASC: CTO PCI Does Not Improve LV Function but Seems to Provide Symptom Relief

TCT 76: Impact of Post-Discharge Dual Antiplatelet Therapy vs Aspirin Alone After CABG in Patients With Left Main Disease: Results from the EXCEL Trial

TCT 4: Prognostic Impact of Nonculprit Chronic Total Occlusions in Infarct-Related Cardiogenic Shock - Results of the Randomized IABP-SHOCK II Trial

TCT 20: Ten-year Clinical Outcome in Patients With Coronary Chronic Total Occlusions not Revascularized by Percutaneous Coronary Intervention According to Left Ventricle Systolic Function

TCT 12: Clinical, Angiographic, and Procedural Correlates of Very Late Absorb Scaffold Thrombosis Multistudy Registry Results

RECAP: A Sham-Controlled Randomized Trial of Radiation Protection in Patients Undergoing PCI

Long-term Absorb BVS Data Continue to Disappoint

FAVOR II China: Diagnostic Accuracy of the Angiographic Quantitative Flow Ratio in Patients With Coronary Artery Disease

ABSORB PSP: Impact of Technique on Early and Late Outcomes Following Coronary Bioresorbable Scaffold Implantation

VALIDATE-SWEDEHEART STEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With STEMI

TCT 9: Absorb Bioresorbable Vascular Scaffold vs Everolimus-Eluting Metallic Stent in Small Vessel Disease -A Propensity Matched Analysis of COMPARE II, RAI, and MAASSTAD-ABSORB Prospective Studies

TCT 99: Safety and Efficacy of Percutaneous Axillary Artery Access for Mechanical Circulatory Support With the Impella© Devices: An Initial Evaluation From the Axillary Access Registry to Monitor Safety (ARMS) MultiCenter Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content